Constraint-Induced Movement Therapy in Chronic Stroke Patients
The Feasibility of a Home-based Constraint-Induced Movement Therapy Program in Chronic Stroke Survivors.
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this study is to evaluate the feasibility of a Home-based Constraint-Induced Movement Therapy (hCIMT) compared to a Modified Constraint-Induced Movement Therapy (mCIMT) delivered in a outpatient setting on upper limb motor recovery in stroke survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Aug 2014
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 19, 2015
CompletedFirst Posted
Study publicly available on registry
January 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedDecember 20, 2017
December 1, 2017
2.8 years
January 19, 2015
December 18, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Changes from baseline in Fugl-Meyer Upper Extremity (FM-UE)
Measure of upper extremity motor impairment. The upper extremity score ranges from 0-66.
1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Secondary Outcomes (6)
Wolf Motor Function Test (WMFT)
1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Nine Hole Peg Test (NHPT
1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Motor Activity Log (MAL)
1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Stroke Impact Scale 3.0 (SIS 3.0)
1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
Motor cortex excitability (single pulse and paired pulse TMS)
1)A week prior to treatment beginning 2) the week after the end of treatment 4) at 3 months follow-up
- +1 more secondary outcomes
Study Arms (2)
mCIMT
ACTIVE COMPARATOR2 hours intensive upper limb practice with shaping techniques supervised by an experienced physiotherapist + 2 hours ADLs at home (supervised by a caregiver) Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.
hCIMT
EXPERIMENTAL2 hours intensive upper limb practice with shaping techniques + 2 hours ADLs supervised by a caregiver. Patients are supposed to wear a mitt on the unaffected hand for 4 hours daily.
Interventions
This intervention is based on 3 main aspects: 1. intensive training of functional tasks with the affected arm (massed practice) 2. constraint of the un-affected hand through a mitt 3. shaping techniques designed to transfer gains to the real world activities The 2 hours massed practice will be performed in a outpatient clinic with a supervision of PT.
This intervention is based on 3 main aspects: 1. intensive training of functional tasks with the affected arm (massed practice) 2. constraint of the un-affected hand through a mitt 3. shaping techniques designed to transfer gains to the real world activities In this group, a comprehensive set of the material necessary to perform the training at home and a booklet containing an explanation of the exercises that can be done will be provided to subjects. In addition, 2 hospital visits will be scheduled to instruct subjects and caregivers on the training and to update activities (1 visit at the beginning + 1 visit after 1 week).
Eligibility Criteria
You may qualify if:
- age \> 18 years and \< 80 years
- diagnosis of first ischemic stroke
- stroke onset \> 6 months prior to study enrollment
- upper extremity hemiparesis with impairment of hand and/or arm:
- active wrist extension ≥20º
- active metacarpophalangeal- and interphalangeal-joints extension ≥ 10°
- muscle tone assessed by the Modified Ashworth Scale (MAS) ≤ 2
- pain assessed by the Visual Analogue Scale (VAS) \<4
You may not qualify if:
- anyone who does not have adequate understanding of verbal or written information in Italian sufficient to complete any test
- impaired cognitive functioning: score less than 24 on the Mini Mental Status Examination (MMSE)
- contraindications to single-pulse transcranial magnetic stimulation (TMS)(TMS will be used to measure cortical excitability): presence of a history of epilepsy, frequent headaches or neck pain, implantable devices (ventriculoperitoneal shunts, pacemakers, intrathecal pumps, intracranial metal implants)
- neurological or psychiatric pathology
- severe cardio-pulmonary, renal, hepatic diseases
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ferrara University Hospital
Ferrara, 44124, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sofia Straudi, MD
Ospedale San Giorgio
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2015
First Posted
January 26, 2015
Study Start
August 1, 2014
Primary Completion
May 1, 2017
Study Completion
August 1, 2017
Last Updated
December 20, 2017
Record last verified: 2017-12